PREEMIE Reauthorization Act of 2025
HB1197, the PREEMIE Reauthorization Act of 2025, reauthorizes federal support for research and education related to premature birth, preterm labor, and the care of preterm and low-birthweight infants. The bill extends the existing PREEMIE research authorization from fiscal years 2019–2023 to fiscal years 2025–2029 and makes a technical correction to prior law. It also changes the status of an interagency working group from permissive to mandatory, requiring the Secretary of Health and Human Services to establish it within 18 months of enactment.
The bill further directs HHS to arrange for the National Academies of Sciences, Engineering, and Medicine to convene experts and produce a report on premature births in the United States. That report must assess the financial costs of premature birth, factors affecting preterm birth rates, opportunities for earlier detection of risk factors, and strategies for improving maternal and infant health. It must also analyze targeted research strategies, state and other best practices for reducing premature birth, and precision medicine and preventive care approaches across the life course.
In practical terms, the bill would continue and expand federal research and coordination efforts under the PREEMIE program, but it does not create a new benefit program or directly change eligibility for health coverage. Its main legal effect is to amend the underlying PREEMIE statute in the U.S. Code and require federal agencies to undertake additional coordination, study, and reporting on preterm birth and related maternal-child health issues.
The overall sentiment reflected by the bill’s introduction is supportive and bipartisan, with sponsors from both parties and no recorded opposition, votes, or committee debate in the provided materials. The measure appears framed as a public health and research reauthorization rather than a controversial policy shift. Because there is no transcript or vote history, there are no documented points of contention in the available record, though the mandated study and interagency coordination could raise questions about administrative burden or federal spending in later consideration.
HB1197 amends the PREEMIE Reauthorization Act of 2018 and related federal maternal and infant health provisions by extending the authorization period for research and education activities through fiscal year 2029, correcting a technical drafting error, and requiring HHS to establish an interagency working group. It also compels a National Academies study and report on preterm birth, which may inform future federal, state, and clinical policy but does not itself alter coverage mandates or create direct individual entitlements.
The bill appears broadly favorable and noncontroversial based on the available record. It was introduced with bipartisan cosponsors and referred to committee without any recorded votes or hearing testimony in the provided materials. The framing is focused on maternal and infant health, research, and prevention, suggesting general support for continuing an existing federal program.
No specific contention is documented in the provided bill text, committee materials, or voting history. The only potentially debatable elements are the required federal study, the mandatory interagency working group, and the implied administrative and research costs, but no member or stakeholder objections are included in the record provided.